David H. Vesole

12.0k citations
53 papers · 2.0k indexed · 1 hit paper · h-index 21
Topics
Multiple Myeloma Research and Treatments (42 papers)Cancer Treatment and Pharmacology (18 papers)Protein Degradation and Inhibitors (18 papers)

In The Last Decade

David H. Vesole

50 papers receiving 1.9k citations

Hit Papers

Phase III Clinical Trial of Thalidomide Plus Dexamethason...20052026201220192005200400600

Peers

David H. Vesole
Comparison fields: 5 of 69
  • Hematology 1.5k
  • Molecular Biology 1.2k
  • Oncology 819
  • Immunology 270
  • Epidemiology 248
Replace Lilian Reich with:
Lilian Reich United States
Ibrahim Aldoss United States
Yener Koç Türkiye
J Pris France
Cecilie Blimark Sweden
Nabih Azar France
Hellmut Ottinger Germany
T. Klingebiel Germany
Edward Kanfer United Kingdom
Woo-Sung Min South Korea
David H. Vesole relative to Lilian Reich United States Lilian Reich's profile →
Citations per field
00.5×3.0×
Lilian Reich · 1×
Citations per year

Countries citing papers authored by David H. Vesole

Since Specialization
Citations

This map shows the geographic impact of David H. Vesole's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Vesole with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Vesole more than expected).

Fields of papers citing papers by David H. Vesole

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Vesole. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Vesole. The network helps show where David H. Vesole may publish in the future.

Co-authorship network of co-authors of David H. Vesole

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Vesole. A scholar is included among the top collaborators of David H. Vesole based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Vesole. David H. Vesole is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 1
5 2
6 3
7 52
8 5
9 23
10 18
11 12
12 19
13 9
14 26
15 0
16 28
17 10
18 51
19 4
20
Transplants for multiple myeloma
10

About David H. Vesole

David H. Vesole is a scholar working on Hematology, Oncology and Molecular Biology, having authored 53 papers that have together received 2.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (42 papers), Cancer Treatment and Pharmacology (18 papers) and Protein Degradation and Inhibitors (18 papers). The work is most often cited by research in Hematology (1.5k citations), Oncology (819 citations) and Internal Medicine (77 citations). David H. Vesole has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Philip R. Greipp, S. Vincent Rajkumar, Rafaël Fonseca, Emily Blood, Mark F. Stinski, Cheryl L. Malone, Sundar Jagannath, Susanna Jacobus, David S. Siegel and Martin M. Oken. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026